NCT00789113View on ClinicalTrials.gov

Determination of Absorption and Elimination of Lamotrigine-XR

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

12

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

January 31, 2011

Study Completion Date

January 31, 2011

Conditions

EpilepsySeizuresBipolar DisorderBipolar Depression

Interventions

DRUG

Extended Release Lamotrigine

Trial Locations (1)

55404

University of Minnesota, Minneapolis

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

University of Minnesota

OTHER

NCT00789113 - Determination of Absorption and Elimination of Lamotrigine-XR | Biotech Hunter | Biotech Hunter